Cargando…
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
BACKGROUND: There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFERON-TB Gold (QFT-G)...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590912/ https://www.ncbi.nlm.nih.gov/pubmed/28886099 http://dx.doi.org/10.1371/journal.pone.0184178 |